)
Edge20 Feb 2026
Dollar General: The Rural Retailer Playbook
How Dollar General built a small-box empire across rural America, scaling value and convenience into one of retail's most durable business models.
Kyntra Bio
Kyntra Bio (KYNB) investor relations material
Kyntra Bio Oppenheimer 36th Annual Healthcare Life Sciences Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Oppenheimer 36th Annual Healthcare Life Sciences Conference summary26 Feb, 2026
Corporate transformation and strategic direction
Rebranded from FibroGen to Kyntra Bio to reflect a shift from fibrosis to oncology and rare disease focus.
Completed the sale of China operations for $220 million, eliminating senior secured debt and extending cash runway to 2028.
Initiated a Phase II trial in metastatic castration-resistant prostate cancer (mCRPC) with FG-3246 and FG-3180.
Actively pursuing business development and capital options for upcoming clinical programs.
Oncology pipeline and clinical progress
FG-3246 targets CD46, a novel epitope highly expressed in mCRPC and other tumors, with a companion PET imaging agent FG-3180.
Phase II monotherapy trial in mCRPC is enrolling, with interim results expected later this year.
Phase I data showed 8.7 months RPFS and a manageable safety profile; GCSF prophylaxis is being used to reduce neutropenia in Phase II.
Recent IST data at ASCO GU showed a strong correlation between CD46 expression (via PET imaging) and response to ADC therapy.
Targeting a 10-month RPFS in Phase II, aiming to match or exceed benchmarks set by Pluvicto.
Roxadustat development and commercial opportunity
Roxadustat is Phase III-ready for anemia in lower-risk myelodysplastic syndrome (MDS), with FDA alignment on trial design and orphan drug designation.
Focused on high transfusion burden patients, where prior data showed significant benefit over placebo.
Oral administration offers a competitive advantage over current therapies requiring clinic visits.
Commercial opportunity is significant, with the leading competitor generating $2.3 billion in 2025 revenue, mostly in the U.S.
Final protocol submitted to FDA; awaiting feedback and planning for trial initiation in the second half of the year.
PET imaging correlation impact on trial design?
Roxadustat Phase 3 funding and partnership strategy
How to achieve 10-month RPFS for FG-3246?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Kyntra Bio earnings date
Q4 20259 Mar, 2026
Kyntra Bio
Next Kyntra Bio earnings date
Q4 20259 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
FibroGen Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of therapies for serious unmet medical needs, particularly in areas like fibrosis, oncology, and anemia. The company’s lead products target conditions such as chronic kidney disease-related anemia and idiopathic pulmonary fibrosis. The company is headquartered in San Francisco, California, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage